ALASTAIR THOMPSON to Gene Expression Regulation, Neoplastic
This is a "connection" page, showing publications ALASTAIR THOMPSON has written about Gene Expression Regulation, Neoplastic.
Connection Strength
0.402
-
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. Breast Cancer Res Treat. 2011 Aug; 128(3):783-94.
Score: 0.124
-
Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study. Br J Cancer. 2014 Feb 04; 110(3):565-72.
Score: 0.037
-
p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell. 2013 Sep 09; 24(3):318-30.
Score: 0.036
-
Gene expression in oestrogen-dependent human breast cancer xenograft tumours. Br J Cancer. 1990 Jul; 62(1):78-84.
Score: 0.029
-
The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. Br J Cancer. 2009 May 19; 100(10):1687-96.
Score: 0.027
-
Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Res. 2008; 10(2):R26.
Score: 0.025
-
Dissecting the molecular mechanisms of human cancer: translating laboratory advances into clinical practice. Surgeon. 2004 Feb; 2(1):1-6.
Score: 0.019
-
Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer. Br J Cancer. 2001 Dec 14; 85(12):1878-82.
Score: 0.016
-
Transforming growth factor beta 1 is unlikely to mediate p53 abnormalities in breast cancer. Br J Surg. 1995 Feb; 82(2):210-1.
Score: 0.010
-
Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status. J Pathol. 2014 Jul; 233(3):238-46.
Score: 0.010
-
Lack of correlation of stem cell markers in breast cancer stem cells. Br J Cancer. 2014 Apr 15; 110(8):2063-71.
Score: 0.009
-
ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR. Breast Cancer Res. 2012 Nov 16; 14(6):R148.
Score: 0.009
-
Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer. Oncotarget. 2012 Jan; 3(1):78-83.
Score: 0.008
-
A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell. 2011 Jul 12; 20(1):79-91.
Score: 0.008
-
Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma. Oncogene. 2011 Nov 17; 30(46):4666-77.
Score: 0.008
-
The RNA helicase p68 modulates expression and function of the ?133 isoform(s) of p53, and is inversely associated with ?133p53 expression in breast cancer. Oncogene. 2010 Dec 09; 29(49):6475-84.
Score: 0.007
-
DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability. Proc Natl Acad Sci U S A. 2010 Jul 27; 107(30):13390-5.
Score: 0.007
-
Usnic acid: a non-genotoxic compound with anti-cancer properties. Anticancer Drugs. 2005 Sep; 16(8):805-9.
Score: 0.005
-
The p53 tumour suppressor gene. Br J Surg. 1998 Nov; 85(11):1460-7.
Score: 0.003
-
Critical determination of the frequency of c-erbB-2 amplification in breast cancer. Br J Cancer. 1994 Sep; 70(3):434-9.
Score: 0.002
-
Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet. 1990 Sep 29; 336(8718):761-3.
Score: 0.002